Drugs / ZD9393
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01073865 | Feb 2010 → Sep 2012 | breast cancer | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZD9393 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01073865 ↗ |
| Route | Subcutaneous | “one subcutaneous depot injection” NCT01073865 ↗ |